Atracurium besilate is a non-depolarising neuromuscular blocking agent with an intermediate duration of action, administered intravenously to produce skeletal muscle relaxation.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Atracurium besilate is the active ingredient of these drugs:
Tunisia
Tunisia
Austria Brazil Cyprus France Hong Kong
Brazil
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):